Background: Bronchiolitis, the leading cause of hospitalization among infants in the United States, is most commonly caused by respiratory syncytial virus (RSV), followed by rhinovirus (RV). Conventional perception is that bronchiolitis is a single entity, albeit with different viral etiologies and degrees of severity. Methods: We conducted a cross-sectional study of nasopharyngeal aspirates from 106 infants hospitalized with bronchiolitis due to either RSV only (80 patients) or RV only (26 patients). We performed metabolomics analysis and 16S ribosomal RNA gene sequencing on all samples and metagenomic sequencing on 58 of 106 samples. Results: Infants with RSV-only and RV-only infections had significantly different nasopharyngeal metabolome profiles (P < .001) and bacterial metagenome profiles (P < .05). RSV-only infection was associated with metabolites from a range of pathways and with a microbiome dominated by Streptococcus pneumoniae. By contrast, RV-only infection was associated with increased levels of essential and nonessential N-acetyl amino acids and with a high relative abundance of Haemophilus influenzae. These co-occurring species were associated with driving the bacterially derived metabolic pathways. Multi-omic analysis showed that both the virus and the microbiome were significantly associated with metabolic function in infants hospitalized with bronchiolitis. Conclusion: Although replication of these findings is necessary, they highlight that bronchiolitis is not a uniform disease between RSV and RV infections, a result with future implications for prevention and treatment.
Background: Bronchiolitis, the leading cause of hospitalization among infants in the United States, is most commonly caused by respiratory syncytial virus (RSV), followed by rhinovirus (RV). Conventional perception is that bronchiolitis is a single entity, albeit with different viral etiologies and degrees of severity. Methods: We conducted a cross-sectional study of nasopharyngeal aspirates from 106 infants hospitalized with bronchiolitis due to either RSV only (80 patients) or RV only (26 patients). We performed metabolomics analysis and 16S ribosomal RNA gene sequencing on all samples and metagenomic sequencing on 58 of 106 samples. Results:Infants with RSV-only and RV-only infections had significantly different nasopharyngeal metabolome profiles (P < .001) and bacterial metagenome profiles (P < .05). RSV-only infection was associated with metabolites from a range of pathways and with a microbiome dominated by Streptococcus pneumoniae. By contrast, RV-only infection was associated with increased levels of essential and nonessential N-acetyl amino acids and with a high relative abundance of Haemophilus influenzae. These co-occurring species were associated with driving the bacterially derived metabolic pathways. Multi-omic analysis showed that both the virus and the microbiome were significantly associated with metabolic function in infants hospitalized with bronchiolitis. Conclusion: Although replication of these findings is necessary, they highlight that bronchiolitis is not a uniform disease between RSV and RV infections, a result with future implications for prevention and treatment.
Authors: Tobias Härtel; Eva Eylert; Christian Schulz; Lothar Petruschka; Philipp Gierok; Stephanie Grubmüller; Michael Lalk; Wolfgang Eisenreich; Sven Hammerschmidt Journal: J Biol Chem Date: 2011-12-13 Impact factor: 5.157
Authors: Shawn L Ralston; Allan S Lieberthal; H Cody Meissner; Brian K Alverson; Jill E Baley; Anne M Gadomski; David W Johnson; Michael J Light; Nizar F Maraqa; Eneida A Mendonca; Kieran J Phelan; Joseph J Zorc; Danette Stanko-Lopp; Mark A Brown; Ian Nathanson; Elizabeth Rosenblum; Stephen Sayles; Sinsi Hernandez-Cancio Journal: Pediatrics Date: 2014-11 Impact factor: 7.124
Authors: Jonathan M Mansbach; Kohei Hasegawa; David M Henke; Nadim J Ajami; Joseph F Petrosino; Chad A Shaw; Pedro A Piedra; Ashley F Sullivan; Janice A Espinola; Carlos A Camargo Journal: J Allergy Clin Immunol Date: 2016-04-06 Impact factor: 10.793
Authors: Alex Poole; Cydney Urbanek; Celeste Eng; Jeoffrey Schageman; Sean Jacobson; Brian P O'Connor; Joshua M Galanter; Christopher R Gignoux; Lindsey A Roth; Rajesh Kumar; Sharon Lutz; Andrew H Liu; Tasha E Fingerlin; Robert A Setterquist; Esteban G Burchard; Jose Rodriguez-Santana; Max A Seibold Journal: J Allergy Clin Immunol Date: 2014-02-02 Impact factor: 10.793
Authors: Orianne Dumas; Jonathan M Mansbach; Tuomas Jartti; Kohei Hasegawa; Ashley F Sullivan; Pedro A Piedra; Carlos A Camargo Journal: Thorax Date: 2016-06-23 Impact factor: 9.139
Authors: Robert A Quinn; Vanessa V Phelan; Katrine L Whiteson; Neha Garg; Barbara A Bailey; Yan Wei Lim; Douglas J Conrad; Pieter C Dorrestein; Forest L Rohwer Journal: ISME J Date: 2015-12-01 Impact factor: 10.302
Authors: Christopher J Stewart; Jonathan M Mansbach; Pedro A Piedra; Laura Toivonen; Carlos A Camargo; Kohei Hasegawa Journal: Pediatr Allergy Immunol Date: 2019-07-18 Impact factor: 6.377
Authors: Christopher J Stewart; Jonathan M Mansbach; Nadim J Ajami; Joseph F Petrosino; Zhaozhong Zhu; Liming Liang; Carlos A Camargo; Kohei Hasegawa Journal: J Infect Dis Date: 2019-05-24 Impact factor: 5.226
Authors: Michimasa Fujiogi; Carlos A Camargo; Yoshihiko Raita; Yury A Bochkov; James E Gern; Jonathan M Mansbach; Pedro A Piedra; Kohei Hasegawa Journal: Allergy Date: 2020-05-05 Impact factor: 13.146
Authors: Carlos E Rodríguez-Martínez; Jose A Castro-Rodriguez; Gustavo Nino; Fabio Midulla Journal: Paediatr Respir Rev Date: 2019-04-12 Impact factor: 2.726
Authors: Michimasa Fujiogi; Carlos A Camargo; Yoshihiko Raita; Yury A Bochkov; James E Gern; Jonathan M Mansbach; Pedro A Piedra; Kohei Hasegawa Journal: Pediatr Allergy Immunol Date: 2020-06-10 Impact factor: 6.377
Authors: Irene Rivero-Calle; Jose Gómez-Rial; Louis Bont; Bradford D Gessner; Melvin Kohn; Ron Dagan; Daniel C Payne; Laia Bruni; Andrew J Pollard; Adolfo García-Sastre; Denise L Faustman; Albert Osterhaus; Robb Butler; Francisco Giménez Sánchez; Francisco Álvarez; Myrsini Kaforou; Xabier Bello; Federico Martinón-Torres Journal: Hum Vaccin Immunother Date: 2020-08-05 Impact factor: 3.452